Zhejiang Xinguang Pharmaceutical Co., Ltd. (SHE:300519)

Market Cap	2.64B +28.3%
Revenue (ttm)	257.07M -5.0%
Net Income	57.94M +33.4%
EPS	0.35 +28.6%
Shares Out	160.00M
PE Ratio	47.25
Forward PE	n/a
Dividend	0.30 (1.82%)
Ex-Dividend Date	May 28, 2025

Volume	3,068,900
Average Volume	3,726,289
Open	16.31
Previous Close	16.46
Day's Range	16.27 - 16.51
52-Week Range	11.13 - 20.36
Beta	0.40
RSI	56.38
Earnings Date	Apr 20, 2026

About SHE:300519

Zhejiang Xinguang Pharmaceutical Co., Ltd. engages in the research and development, production, and sales of Chinese patent medicines, chemical medicines, and health food in China. It offers pharmaceutical products that cover respiratory, digestive, and urinary systems, as well as cardiovascular, cerebrovascular, trauma, and pediatric diseases. The company was incorporated in 1998 and is headquartered in Shengzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 316
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300519

Financial Performance

In 2024, SHE:300519's revenue was 267.66 million, a decrease of -1.01% compared to the previous year's 270.40 million. Earnings were 50.39 million, a decrease of -21.70%.